Process View
36 genes annotated in human
DOID:612
An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "primary immunodeficiency disease"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NCF1 | neutrophil cytosolic factor 1 | 1.000 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 1.000 | Human | |
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 1.000 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.999 | Human | |
| TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 0.988 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.987 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.984 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.971 | ||
| TAPBP | TAP binding protein (tapasin) | 0.968 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.964 | ||
| BLNK | B-cell linker | 0.933 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.931 | ||
| APLF | aprataxin and PNKP like factor | 0.902 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.877 | Human | |
| CD19 | CD19 molecule | 0.792 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.791 | ||
| PRKCB | protein kinase C, beta | 0.769 | ||
| PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.760 | ||
| CD22 | CD22 molecule | 0.608 | ||
| TRIM9 | tripartite motif containing 9 | 0.562 | ||
| CD79B | CD79b molecule, immunoglobulin-associated beta | 0.534 | ||
| PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.522 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.472 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.468 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.432 | Human | |
| SYK | spleen tyrosine kinase | 0.364 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.313 | ||
| PRKCA | protein kinase C, alpha | 0.259 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.225 | ||
| ACTB | actin, beta | 0.220 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.188 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.187 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.184 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.178 | ||
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.151 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.148 | ||
| CDCP1 | CUB domain containing protein 1 | 0.146 | ||
| PRKCD | protein kinase C, delta | 0.127 | ||
| BLK | B lymphoid tyrosine kinase | 0.119 | Human | |
| HLA-F | major histocompatibility complex, class I, F | 0.113 | ||
| TSPAN4 | tetraspanin 4 | 0.099 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.096 | ||
| MZB1 | marginal zone B and B1 cell-specific protein | 0.096 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.093 | ||
| INO80B | INO80 complex subunit B | 0.090 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.089 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.079 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.079 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.078 | ||
| IL4R | interleukin 4 receptor | 0.076 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.076 | ||
| B2M | beta-2-microglobulin | 0.075 | ||
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.074 | ||
| CD9 | CD9 molecule | 0.073 | Human | |
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.073 | ||
| TCL1A | T-cell leukemia/lymphoma 1A | 0.070 | ||
| POU2AF1 | POU class 2 associating factor 1 | 0.067 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.057 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.053 | ||
| FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.051 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.043 | ||
| VPREB3 | pre-B lymphocyte 3 | 0.043 | ||
| HLA-C | major histocompatibility complex, class I, C | 0.040 | ||
| IRF1 | interferon regulatory factor 1 | 0.040 | ||
| IL32 | interleukin 32 | 0.038 | ||
| ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.037 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.037 | ||
| PPIF | peptidylprolyl isomerase F | 0.035 | ||
| PNOC | prepronociceptin | 0.034 | ||
| LY86 | lymphocyte antigen 86 | 0.034 | ||
| C3 | complement component 3 | 0.033 | Human | |
| CD1C | CD1c molecule | 0.031 | ||
| CD27 | CD27 molecule | 0.031 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.031 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.029 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.029 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.029 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.028 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.028 | ||
| IL7R | interleukin 7 receptor | 0.028 | ||
| IGL@ | immunoglobulin lambda locus | 0.027 | ||
| CD99 | CD99 molecule | 0.026 | ||
| IRF8 | interferon regulatory factor 8 | 0.026 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.026 | ||
| SELL | selectin L | 0.025 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.024 | Human | |
| MSN | moesin | 0.024 | ||
| HLA-DOB | major histocompatibility complex, class II, DO beta | 0.024 | ||
| PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.024 | ||
| TAGLN2 | transgelin 2 | 0.024 | ||
| CD72 | CD72 molecule | 0.023 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.023 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.023 | ||
| RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 0.023 | ||
| STAP1 | signal transducing adaptor family member 1 | 0.022 | ||
| IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 0.022 | ||
| CD180 | CD180 molecule | 0.022 | ||
| PASK | PAS domain containing serine/threonine kinase | 0.022 | ||
| IRF4 | interferon regulatory factor 4 | 0.022 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.021 | ||
| PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.021 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.021 | ||
| RHOH | ras homolog gene family, member H | 0.021 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.021 | ||
| STK10 | serine/threonine kinase 10 | 0.021 | ||
| NHEJ1 | nonhomologous end-joining factor 1 | 0.021 | ||
| GLA | galactosidase, alpha | 0.020 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.020 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.020 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.019 | ||
| CALR | calreticulin | 0.019 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.019 | ||
| FLNA | filamin A, alpha | 0.018 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.018 | ||
| CD86 | CD86 molecule | 0.018 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.018 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.018 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.018 | ||
| PAX5 | paired box 5 | 0.017 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.017 | ||
| PIM2 | pim-2 oncogene | 0.017 | ||
| GPR18 | G protein-coupled receptor 18 | 0.017 | ||
| THOC5 | THO complex 5 | 0.017 | ||
| GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.016 | ||
| CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 0.016 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.015 | ||
| CD52 | CD52 molecule | 0.015 | ||
| LRMP | lymphoid-restricted membrane protein | 0.015 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.015 | ||
| ZNF259 | zinc finger protein 259 | 0.015 | ||
| DLG5 | discs, large homolog 5 (Drosophila) | 0.014 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.014 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.014 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.014 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.014 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.014 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.014 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.014 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.014 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.014 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.013 | ||
| ITK | IL2-inducible T-cell kinase | 0.013 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.013 | ||
| P2RX5 | purinergic receptor P2X, ligand-gated ion channel, 5 | 0.013 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.013 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.013 | Human | |
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.013 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.012 | ||
| IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.012 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.012 | ||
| GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 | 0.012 | ||
| CD37 | CD37 molecule | 0.012 | ||
| PSMB10 | proteasome (prosome, macropain) subunit, beta type, 10 | 0.012 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.012 | ||
| CD2AP | CD2-associated protein | 0.012 | ||
| ACTN4 | actinin, alpha 4 | 0.012 | ||
| CD38 | CD38 molecule | 0.012 | ||
| GTF2I | general transcription factor IIi | 0.012 | ||
| FAM65B | family with sequence similarity 65, member B | 0.012 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.012 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.012 | ||
| LAT2 | linker for activation of T cells family, member 2 | 0.012 | ||
| DDOST | dolichyl-diphosphooligosaccharide--protein glycosyltransferase | 0.012 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.012 | ||
| FCRLA | Fc receptor-like A | 0.012 | ||
| VPREB1 | pre-B lymphocyte 1 | 0.012 | ||
| ZHX1 | zinc fingers and homeoboxes 1 | 0.011 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.011 | ||
| HCP5 | HLA complex P5 | 0.011 | ||
| TIFA | TRAF-interacting protein with forkhead-associated domain | 0.011 | ||
| CUTA | cutA divalent cation tolerance homolog (E. coli) | 0.011 | ||
| BANK1 | B-cell scaffold protein with ankyrin repeats 1 | 0.011 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.011 | ||
| MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0.011 | ||
| ERMP1 | endoplasmic reticulum metallopeptidase 1 | 0.011 | ||
| TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 | 0.011 | ||
| CPT1A | carnitine palmitoyltransferase 1A (liver) | 0.011 | ||
| SIRT6 | sirtuin 6 | 0.011 | ||
| FCRL2 | Fc receptor-like 2 | 0.011 | ||
| IL7 | interleukin 7 | 0.011 | ||
| GP1BB | glycoprotein Ib (platelet), beta polypeptide | 0.011 | ||
| SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.011 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.011 | ||
| HK2 | hexokinase 2 | 0.011 | ||
| RGS14 | regulator of G-protein signaling 14 | 0.011 | ||
| PLXND1 | plexin D1 | 0.011 | ||
| CD2 | CD2 molecule | 0.011 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.011 | ||
| CD151 | CD151 molecule (Raph blood group) | 0.010 | ||
| GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | 0.010 | ||
| HP | haptoglobin | 0.010 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.010 | ||
| HCK | hemopoietic cell kinase | 0.010 | Human | |
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.010 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.009 | ||
| RFXAP | regulatory factor X-associated protein | 0.008 | ||
| IGLL1 | immunoglobulin lambda-like polypeptide 1 | 0.008 | ||
| ADA | adenosine deaminase | 0.007 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.007 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.007 | ||
| C5 | complement component 5 | 0.006 | ||
| ICOS | inducible T-cell co-stimulator | 0.005 | ||
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.005 | ||
| RFXANK | regulatory factor X-associated ankyrin-containing protein | 0.005 | ||
| CFI | complement factor I | 0.004 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.004 | ||
| LRRC8A | leucine rich repeat containing 8 family, member A | 0.003 | ||
| TNFRSF13C | tumor necrosis factor receptor superfamily, member 13C | 0.003 | ||
| LIG4 | ligase IV, DNA, ATP-dependent | 0.003 | ||
| LRBA | LPS-responsive vesicle trafficking, beach and anchor containing | 0.003 | ||
| CD81 | CD81 molecule | 0.002 | ||
| TBX1 | T-box 1 | 0.001 | ||
| PNP | purine nucleoside phosphorylase | 0.001 | ||
| AK2 | adenylate kinase 2 | 0.001 |